Agree, quite a list and really do not understand why Truvada there. Tenofovir is now off patent and a generic version of Truvada will be available in 2020. The cost of generic Truvada in a France is ~ € 160/mo.
-
-
-
And much less in the UK. This is so wrong!
- Näytä vastaukset
Uusi keskustelu -
-
-
For shame. I'm sure we'll see the same thing happen with Descovy until it goes generic in 2026. Good thing the vast majority of PrEP users can safely use generic TDF/FTC starting next year!
-
A cynic may say “good thing most pts can use generic Truvada next year… Until it mysteriously goes on shortage/back order/recall.” I think there are way more dynamics going on than the ICER report can take into account. It’s the monopolies in drug manufacturing that is at fault
Keskustelun loppu
Uusi keskustelu -
-
-
If differential pricing by indication were possible while striving for value-based prices, the average Truvada price should be going down over time as it’s used for PrEP by more and lower risk people (good but less cost-effective). The price is still a bargain for HIV treatment.
Kiitos. Käytämme tätä aikajanasi parantamiseen. KumoaKumoa
-
-
-
Agree. The article mentions that
@realDonaldTrump wants to decrease drug prices.#Truvada & TAF-based drugs would be a great place to begin. High#HIV and#PrEP drug costs are an obstacle to efforts to#EndTheHIVEpidemic.@GileadSciences could be a champion!@HIVMA@HHSGov -
Absolutely!
Keskustelun loppu
Uusi keskustelu -
-
-
Government costs of 28-30 (month) tablets of PrEP in 23 countries in Europe and Central Asia. Does this make sense?pic.twitter.com/fpudHzAZB2
-
Wow and no!
Keskustelun loppu
Uusi keskustelu -
-
-
We need access to generic substitutions
Kiitos. Käytämme tätä aikajanasi parantamiseen. KumoaKumoa
-
Lataaminen näyttää kestävän hetken.
Twitter saattaa olla ruuhkautunut tai ongelma on muuten hetkellinen. Yritä uudelleen tai käy Twitterin tilasivulla saadaksesi lisätietoja.